|
|
| (13 intermediate revisions by 2 users not shown) |
| Line 1: |
Line 1: |
| − | {{Bio
| + | #REDIRECT [[AltUser:Guglielmo_Roma]] |
| − | |Name=Guglielmo
| + | |
| − | |Surnames=Roma
| + | |
| − | |Photo=Guglielmo Roma.jpg
| + | |
| − | |Email_address=guglielmo.roma@crg.es
| + | |
| − | |Phone=+34 93 316 01 81
| + | |
| − | |HomePage=[http://es.linkedin.com/in/guglielmoroma LinkedIn]
| + | |
| − | }}
| + | |
| − | Guglielmo holds nine years of experience in bioinformatics in both Academic ([http://www.ceinge.unina.it/ CEINGE], [http://www.tigem.it/ TIGEM], currently [http://www.crg.cat/ CRG]) and Pharmaceutical environments ([http://www.merckserono.com/en/index.html MerckSerono International]). He obtained a master degree in Biology (University of Naples 1996-2001), a post-lauream Master in Bioinformatics (University of Benevento, 2002-2003) and a post-lauream Specialization in Clinical Biochemistry (Second University of Naples, 2001-2006), and is particularly interested into -omics sciences. As bioinformatician, he has contributed to several research projects (e.g. the discovery of novel transcripts expressed in ES cells [http://www.ncbi.nlm.nih.gov/pubmed/17540781], the development of biological resources and databases [http://www.ncbi.nlm.nih.gov/pubmed/19906694][http://www.ncbi.nlm.nih.gov/pubmed/17942430], the identification of disease genes using comparative genomics approaches [http://www.ncbi.nlm.nih.gov/pubmed/16174644] [http://sulfabase.tigem.it/], the discovery of gene regulatory networks), as well as was involved in the identification and validation of clinical biomarkers (Phase Ia and Ib, in MerckSerono). He currently leads the CRG Bioinformatics Core Facility with the main goal to provide scientists, at CRG/PRBB and external institutions, with computational and data analysis expertise.
| + | |
| − | | + | |
| − | Guglielmo Roma may be contacted at +34 933160181 or by e-mail at the address mailto:guglielmo.roma@crg.es.
| + | |
